2nd Quarter - Report

VAN SCOYOC ASSOCIATES for HUMANIGEN, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Therapeutics manufacturing related issues, as follows: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Implementation of Public Law 116-260, Consolidated Appropriations Act, FY2021 Public Law 117-2, American Rescue Plan Act of 2021

LobbyistCovered position, as disclosed
CARLISLE CLARKE —
JEFFERY S TRINCA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Manufacturing MAN

Therapeutics manufacturing, review and authorization issues Supply chain and National Stockpile preparedness related issues Therapeutics manufacturing related issues, as follows: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Implementation of Public Law 116-260, Consolidated Appropriations Act, FY2021

LobbyistCovered position, as disclosed
CARLISLE CLARKE —
MATT HENKEN New Legislative Director, Congressman Ed Perlmutter; Associate Staff, House Committee on Rules; and Congressional Aide, Congressman Mark Udall
JENNIFER LATOURETTE —
JEFFERY S TRINCA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Therapeutics manufacturing, review and authorization issues Supply chain and National Stockpile preparedness related issues Therapeutics manufacturing related issues, as follows: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Implementation of Public Law 116-260, Consolidated Appropriations Act, FY2021

LobbyistCovered position, as disclosed
CARLISLE CLARKE —
MATT HENKEN New Legislative Director, Congressman Ed Perlmutter; Associate Staff, House Committee on Rules; and Congressional Aide, Congressman Mark Udall
JENNIFER LATOURETTE —
JEFFERY S TRINCA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Therapeutics manufacturing, review and authorization issues Supply chain and National Stockpile preparedness related issues Therapeutics manufacturing related issues, as follows: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Implementation of Public Law 116-260, Consolidated Appropriations Act, FY2021

LobbyistCovered position, as disclosed
CARLISLE CLARKE —
MATT HENKEN New Legislative Director, Congressman Ed Perlmutter; Associate Staff, House Committee on Rules; and Congressional Aide, Congressman Mark Udall
JENNIFER LATOURETTE —
JEFFERY S TRINCA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.